Partner With Us

Advancing Cognitive and Wakefulness Therapies Together

Modamane Ltd is seeking partnerships with organisations interested in developing or commercialising our patented combination therapy of modafinil and Lion’s Mane extract. This formulation offers a differentiated therapeutic strategy with potential applications in ADHD, narcolepsy, and cognitive enhancement.

We welcome discussions with pharmaceutical companies, biotechnology firms, digital therapeutics platforms, and clinical research organisations.

Collaboration Opportunities

1. Licensing Agreements

   Exclusive or non-exclusive licensing rights for:

• UK territory

• European markets

• Global development rights

2. Co-Development Partnerships

Joint programmes for:

• Preclinical validation

• Clinical trials

• Regulatory advancement

3. Territory Exclusivity

   Opportunities for partners with strong distribution or market presence.

4. Technology Integration

   Digital therapeutics or telemedicine platforms can integrate the patented combination into their treatment pathways.

Why Partner With Modamane

• Strong patent protection covering composition, mechanism, and therapeutic application

• Dual-mechanism approach combining wakefulness promotion with neurotrophic support

• Applicability across high-value therapeutic markets

• Flexible partnership structures tailored to strategic goals

• Early partnership advantage with opportunities for favourable licensing terms

Get in Touch

For partnership, licensing, or business development enquiries,

please fill out the form or contact:

Email: Marcus@modamane.co.uk

Address: Modamane Ltd, LCB Depot, 31 Rutland Street

Leicester, United Kingdom, LE1 1RE.